Bashar Khazaal | Medical Microbiology | Best Researcher Award

Best Researcher Award

Bashar Khazaal – College of Medicine, University of Anbar, Iraq

Bashar Khazaal

Affiliation College of Medicine, University of Anbar
Country Iraq
Scopus ID 61012273700
Subject Area Medical Microbiology
Event World Top Scientists Awards

Bashar Khazaal is an academic researcher affiliated with the College of Medicine, University of Anbar, Iraq. His indexed research includes work examining immunological markers associated with active pulmonary tuberculosis, including cases with and without pre-existing asthma. His research profile is indexed in Scopus under author ID 61012273700. [1]

Abstract

Bashar Khazaal’s research profile features a publication investigating total immunoglobulin E (IgE), purified protein derivative (PPD)-reactive IgE and prostaglandin D2 in patients with active pulmonary tuberculosis, with consideration of pre-existing asthma. The study addresses the relationship between immunological responses and respiratory conditions, representing a contribution to research at the intersection of medical microbiology, immunology and pulmonary medicine. [1]

Keywords

Best Researcher Award, Best Researcher Award in Medical Microbiology, Medical Microbiology Research Award, Pulmonary Tuberculosis Research Award, Immunology Research Award, Respiratory Medicine Research Award.

Introduction

Medical microbiology investigates microorganisms and their relationships with human health and disease. Pulmonary tuberculosis remains an important subject in infectious disease research, particularly regarding immune responses and associated respiratory conditions. Khazaal’s indexed publication explores selected immunological indicators in active pulmonary tuberculosis, providing a research perspective on the interaction between tuberculosis and pre-existing asthma. [1]

Research Profile

Khazaal is associated with the College of Medicine at the University of Anbar in Iraq. According to the supplied Scopus profile, his author record contains one indexed document, zero citations and an h-index of zero. These bibliometric indicators provide a snapshot of the indexed publication record rather than a comprehensive assessment of academic activity. [1]

Research Contributions

The indexed study examines total IgE, PPD-reactive IgE and prostaglandin D2 in active pulmonary tuberculosis patients, comparing individuals with and without pre-existing asthma. Its subject matter connects infectious disease investigation with immunological analysis and respiratory health. The publication reflects an interdisciplinary research approach relevant to medical microbiology and pulmonary medicine. [2]

Publications

Bashar Khazaal’s research focuses on medical microbiology, particularly immunological aspects of pulmonary tuberculosis and respiratory health. His published work explores the relationship between immunological markers and active pulmonary tuberculosis in patients with and without pre-existing asthma. His research contributes to the broader understanding of infectious diseases and associated immune responses. The publication is indexed in Scopus and forms part of his documented academic research profile. [1]

Research Impact

The Scopus record reports zero citations for the indexed document at the time represented by the supplied profile. Although citation counts and h-index are useful bibliometric measures, they should be interpreted in the context of publication timelines, research discipline and indexing coverage. The publication’s focus on tuberculosis-related immune markers provides a relevant subject for continued investigation. [1]

Award Suitability

The Best Researcher Award recognizes scholarly contributions, research engagement and subject-specific academic work. Khazaal’s indexed publication in medical microbiology demonstrates research activity involving pulmonary tuberculosis and immunological indicators. His academic affiliation and documented publication provide information for consideration within the award’s research recognition framework. Final award eligibility and selection remain subject to the organizer’s evaluation criteria.

Conclusion

Bashar Khazaal’s research profile reflects academic work in medical microbiology, with an indexed publication addressing immunological markers in active pulmonary tuberculosis. His affiliation with the University of Anbar and documented research provide a foundation for academic recognition and further research development. The profile offers a concise overview of his currently documented Scopus publication record. [1]

References

  1. Khazaal, B. M., Lafi, S. A., & Abdulateef, Y. M. (2026). Total IgE, PPD-reactive IgE and prostaglandin D2 in active pulmonary tuberculosis with and without pre-existing asthma. Egyptian Journal of Bronchology. Scopus indexed publication record.https://link.springer.com/article/10.1186/s43168-026-00705-1
  2. Elsevier. (n.d.). Scopus author details: Bashar Khazaal, Author ID 61012273700. Scopus Preview. https://www.scopus.com/authid/detail.uri?authorId=61012273700
  3. World Top Scientists Awards. (n.d.). Official awards website. https://worldtopscientists.com/

Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

Dr. Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

MD at Izmir City Hospital, Turkey

Dr. Tuba Yüce İnel is a dedicated physician and researcher specializing in internal medicine, immunology, and rheumatology. With extensive experience in clinical practice and academic research, she has contributed significantly to the study of autoimmune diseases, inflammatory conditions, and rheumatological disorders. Her research focuses on understanding disease mechanisms and improving treatment approaches for complex conditions such as systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. Dr. İnel has published multiple papers in high-impact international journals, providing valuable insights into disease management and patient outcomes. Actively involved in scientific collaborations, she has participated in various national research projects aimed at advancing rheumatological medicine. She has also been recognized for her contributions with prestigious awards, highlighting her expertise and commitment to medical science.

Professional Profile

Education

Dr. Tuba Yüce İnel began her medical education at Hacettepe University School of Medicine, where she earned her Bachelor’s degree in Medicine in 2012. She then pursued a specialization in internal medicine at Istanbul University Faculty of Medicine, completing her training in 2017 with a thesis on the side effects of immunosuppressive treatments in primary glomerular diseases. Her academic journey continued with a minor specialization in Immunology and Rheumatology at Dokuz Eylül University, where she completed her training in 2022. Through her education at leading Turkish medical institutions, Dr. İnel gained extensive clinical expertise and research experience, shaping her career in autoimmune and inflammatory diseases.

Professional Experience

Dr. İnel has held key positions as a Research Assistant at both Istanbul University (2012-2017) and Dokuz Eylül University (2018-present), where she has contributed to research and medical education. She has played a significant role in clinical studies related to autoimmune diseases, particularly focusing on systemic sclerosis and inflammatory pathways. Additionally, she has been actively involved in teaching and mentoring medical students and residents, sharing her expertise in rheumatology and immunology. Her professional journey includes participation in several government-funded scientific research projects, further solidifying her role as a leading researcher in rheumatology.

Research Interests

Dr. İnel’s research focuses on autoimmune diseases, inflammatory rheumatologic disorders, and immunology, with a particular emphasis on systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. She has explored the role of immune pathways, including the NEK7-NLRP3 inflammasome pathway, in disease progression and treatment response. Her studies on plasma arginine-citrulline levels in systemic sclerosis have contributed to understanding disease severity and malabsorption mechanisms. Additionally, her research on obesity’s impact on ankylosing spondylitis treatment has provided real-world data on therapeutic outcomes. She continues to investigate novel biomarkers and targeted treatments to improve patient care and enhance therapeutic strategies in rheumatology.

Awards and Honors

Dr. İnel’s outstanding research has earned her recognition and accolades within the medical community. In 2022, she won the First Prize for Oral Presentation in Spondyloarthritis, awarded by the Turkish Rheumatology Association, highlighting her excellence in presenting groundbreaking research. Her work has been published in internationally recognized journals, showcasing her significant contributions to rheumatology and immunology. She is also an active member of the Turkish Rheumatology Association, reflecting her commitment to advancing knowledge and collaboration in her field. Through her academic achievements, research excellence, and clinical expertise, Dr. İnel continues to establish herself as a leading figure in rheumatology research.

Conclusion

Dr. Tuba Yüce İnel is a strong candidate for the Best Researcher Award due to her academic achievements, impactful research in rheumatology, national recognition, and continuous contributions to scientific literature. If she enhances international collaborations, takes leadership roles in research projects, and secures external funding, her candidacy would become even more compelling.

Publications Top Noted

1. A Life-Threatening Manifestation of Granulomatosis with Polyangiitis: Subglottic Stenosis

  • Authors: Yüce-İnel, T., Uslu, S.
  • Year: 2024
  • Journal: Archives of Rheumatology
  • Citations: 0

2. Assessing Safety and Efficacy of TNFi Treatment in Late-Onset Ankylosing Spondylitis: A TURKBIO Registry Study

  • Authors: Uslu, S., Gülle, S., Sen, G., Akkoç, N., Onen, F., Yüce-İnel, T.
  • Year: 2024
  • Journal: Scientific Reports
  • Citations: 4